Beam Therapeutics BEAM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's accounts payable?
- Beam Therapeutics (BEAM) reported accounts payable of $12.29M in Q1 2026.
- How has Beam Therapeutics's accounts payable changed year-over-year?
- Beam Therapeutics's accounts payable increased by 59.6% year-over-year, from $7.7M to $12.29M.
- What is the long-term trend for Beam Therapeutics's accounts payable?
- Over 4 years (2021 to 2025), Beam Therapeutics's accounts payable has grown at a 5.4% compound annual growth rate (CAGR), from $30.77M to $38.03M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.